Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Gyre Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
GYRE
Nasdaq
8731
https://www.gyretx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Gyre Therapeutics Inc
Gyre Therapeutics Inc (GYRE) Announces Full Year 2023 Financial Outcomes and Business Progress
- Mar 28th, 2024 9:32 am
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
- Mar 26th, 2024 10:00 am
Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
- Mar 21st, 2024 11:00 am
Totus Medicines Announces Appointment of Nassim Usman, Ph.D., as President & CEO and the Closing of a $66M Series B Funding
- Dec 15th, 2023 2:04 pm
Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting
- Nov 13th, 2023 12:00 pm
Scroll